Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 12 entries
Sorted by: Best Match Show Resources per page
[Distinctive morphological and functional changes in retinal ganglion cells associated with normal aging and early stage of glaucoma].

Vestnik oftalmologii

Zueva MV, Arapiev MU, Tsapenko IV, Lovpache DN, Maglakelidze NM, Lantukh EP.
PMID: 27030432
Vestn Oftalmol. 2016 Jan-Feb;132(1):36-42. doi: 10.17116/oftalma2016132136-42.

UNLABELLED: Early diagnosis of primary open-angle glaucoma (POAG) is closely connected with detection of normal age-related changes in the retina. It is also essential to develop reliable methods for quantitative evaluation of retinal nerve fiber layer (RNFL) thickness and...

Cite
Zueva MV, Arapiev MU, Tsapenko IV, et al. Morfofunktsionalnye osobennosti izmeneniya ganglioznykh kletok setchatki pri fiziologicheskom starenii i v rannei stadii glaukomy. [Distinctive morphological and functional changes in retinal ganglion cells associated with normal aging and early stage of glaucoma]. Vestn Oftalmol. 2016;132(1):36-42doi: 10.17116/oftalma2016132136-42.
Zueva, M. V., Arapiev, M. U., Tsapenko, I. V., Lovpache, D. N., Maglakelidze, N. M., & Lantukh, E. P. (2016). Morfofunktsionalnye osobennosti izmeneniya ganglioznykh kletok setchatki pri fiziologicheskom starenii i v rannei stadii glaukomy. [Distinctive morphological and functional changes in retinal ganglion cells associated with normal aging and early stage of glaucoma]. Vestnik oftalmologii, 132(1), 36-42. https://doi.org/10.17116/oftalma2016132136-42
Zueva, M V, et al. "Morfofunktsionalnye osobennosti izmeneniya ganglioznykh kletok setchatki pri fiziologicheskom starenii i v rannei stadii glaukomy." [Distinctive morphological and functional changes in retinal ganglion cells associated with normal aging and early stage of glaucoma]. Vestnik oftalmologii vol. 132,1 (2016): 36-42. doi: https://doi.org/10.17116/oftalma2016132136-42
Zueva MV, Arapiev MU, Tsapenko IV, Lovpache DN, Maglakelidze NM, Lantukh EP. Morfofunktsionalnye osobennosti izmeneniya ganglioznykh kletok setchatki pri fiziologicheskom starenii i v rannei stadii glaukomy. [Distinctive morphological and functional changes in retinal ganglion cells associated with normal aging and early stage of glaucoma]. Vestn Oftalmol. 2016 Jan-Feb;132(1):36-42. doi: 10.17116/oftalma2016132136-42. Russian. PMID: 27030432.
Copy Download .nbib Format: NLM
Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001.

Clinical cancer research : an official journal of the American Association for Cancer Research

Wiedermann U, Garner-Spitzer E, Chao Y, Maglakelidze M, Bulat I, Dechaphunkul A, Arpornwirat W, Charoentum C, Yen CJ, Yau TC, Tanasanvimon S, Maneechavakajorn J, Sookprasert A, Bai LY, Chou WC, Ungtrakul T, Drinic M, Tobias J, Zielinski CC, Chong L, Ede NJ, Marino MT, Good AJ.
PMID: 33879458
Clin Cancer Res. 2021 Jul 01;27(13):3649-3660. doi: 10.1158/1078-0432.CCR-20-3742. Epub 2021 Apr 20.

PURPOSE: HER2/neu is overexpressed in up to 30% of gastroesophageal adenocarcinomas (GEA) and linked to poor prognosis. Recombinant mAbs to treat HER2/neu-overexpressing cancers are effective with limitations, including resistance and toxicity. Therefore, we developed a therapeutic B-cell epitope vaccine...

Cite
Wiedermann U, Garner-Spitzer E, Chao Y, et al. Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001. Clin Cancer Res. 2021;27(13):3649-3660doi: 10.1158/1078-0432.CCR-20-3742.
Wiedermann, U., Garner-Spitzer, E., Chao, Y., Maglakelidze, M., Bulat, I., Dechaphunkul, A., Arpornwirat, W., Charoentum, C., Yen, C. J., Yau, T. C., Tanasanvimon, S., Maneechavakajorn, J., Sookprasert, A., Bai, L. Y., Chou, W. C., Ungtrakul, T., Drinic, M., Tobias, J., Zielinski, C. C., Chong, L., Ede, N. J., Marino, M. T., & Good, A. J. (2021). Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(13), 3649-3660. https://doi.org/10.1158/1078-0432.CCR-20-3742
Wiedermann, Ursula, et al. "Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,13 (2021): 3649-3660. doi: https://doi.org/10.1158/1078-0432.CCR-20-3742
Wiedermann U, Garner-Spitzer E, Chao Y, Maglakelidze M, Bulat I, Dechaphunkul A, Arpornwirat W, Charoentum C, Yen CJ, Yau TC, Tanasanvimon S, Maneechavakajorn J, Sookprasert A, Bai LY, Chou WC, Ungtrakul T, Drinic M, Tobias J, Zielinski CC, Chong L, Ede NJ, Marino MT, Good AJ. Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001. Clin Cancer Res. 2021 Jul 01;27(13):3649-3660. doi: 10.1158/1078-0432.CCR-20-3742. Epub 2021 Apr 20. PMID: 33879458.
Copy Download .nbib Format: NLM
A comparison of self-reported to cotinine-detected smoking status among adults in Georgia.

European journal of public health

Williams J, Rakovac I, Loyola E, Sturua L, Maglakelidze N, Gamkrelidze A, Mauer-Stender K, Mikkelsen B, Breda J.
PMID: 32951029
Eur J Public Health. 2020 Oct 01;30(5):1037. doi: 10.1093/eurpub/ckaa160.

No abstract available.

Cite
Williams J, Rakovac I, Loyola E, et al. A comparison of self-reported to cotinine-detected smoking status among adults in Georgia. Eur J Public Health. 2020;30(5):1037doi: 10.1093/eurpub/ckaa160.
Williams, J., Rakovac, I., Loyola, E., Sturua, L., Maglakelidze, N., Gamkrelidze, A., Mauer-Stender, K., Mikkelsen, B., & Breda, J. (2020). A comparison of self-reported to cotinine-detected smoking status among adults in Georgia. European journal of public health, 30(5), 1037. https://doi.org/10.1093/eurpub/ckaa160
Williams, Julianne, et al. "A comparison of self-reported to cotinine-detected smoking status among adults in Georgia." European journal of public health vol. 30,5 (2020): 1037. doi: https://doi.org/10.1093/eurpub/ckaa160
Williams J, Rakovac I, Loyola E, Sturua L, Maglakelidze N, Gamkrelidze A, Mauer-Stender K, Mikkelsen B, Breda J. A comparison of self-reported to cotinine-detected smoking status among adults in Georgia. Eur J Public Health. 2020 Oct 01;30(5):1037. doi: 10.1093/eurpub/ckaa160. PMID: 32951029; PMCID: PMC7536248.
Copy Download .nbib Format: NLM
In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host disease.

JCI insight

Buxbaum NP, Farthing DE, Maglakelidze N, Lizak M, Merkle H, Carpenter AC, Oliver BU, Kapoor V, Castro E, Swan GA, Dos Santos LM, Bouladoux NJ, Bare CV, Flomerfelt FA, Eckhaus MA, Telford WG, Belkaid Y, Bosselut RJ, Gress RE.
PMID: 28614804
JCI Insight. 2017 Jun 15;2(12). doi: 10.1172/jci.insight.92851. eCollection 2017 Jun 15.

Hematopoietic stem cell transplantation (HSCT) offers a cure for cancers that are refractory to chemotherapy and radiation. Most HSCT recipients develop chronic graft-versus-host disease (cGVHD), a systemic alloimmune attack on host organs. Diagnosis is based on clinical signs and...

Cite
Buxbaum NP, Farthing DE, Maglakelidze N, et al. In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host disease. JCI Insight. 2017;2(12)doi: 10.1172/jci.insight.92851.
Buxbaum, N. P., Farthing, D. E., Maglakelidze, N., Lizak, M., Merkle, H., Carpenter, A. C., Oliver, B. U., Kapoor, V., Castro, E., Swan, G. A., Dos Santos, L. M., Bouladoux, N. J., Bare, C. V., Flomerfelt, F. A., Eckhaus, M. A., Telford, W. G., Belkaid, Y., Bosselut, R. J., & Gress, R. E. (2017). In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host disease. JCI insight, 2(12), . https://doi.org/10.1172/jci.insight.92851
Buxbaum, Nataliya P, et al. "In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host disease." JCI insight vol. 2,12 (2017). doi: https://doi.org/10.1172/jci.insight.92851
Buxbaum NP, Farthing DE, Maglakelidze N, Lizak M, Merkle H, Carpenter AC, Oliver BU, Kapoor V, Castro E, Swan GA, Dos Santos LM, Bouladoux NJ, Bare CV, Flomerfelt FA, Eckhaus MA, Telford WG, Belkaid Y, Bosselut RJ, Gress RE. In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host disease. JCI Insight. 2017 Jun 15;2(12). doi: 10.1172/jci.insight.92851. eCollection 2017 Jun 15. PMID: 28614804; PMCID: PMC5470940.
Copy Download .nbib Format: NLM
A combined opiate agonist and antagonist treatment reduces prolactin secreting pituitary tumor growth.

Journal of cell communication and signaling

Maglakelidze G, Wynne O, Sarkar DK.
PMID: 28144772
J Cell Commun Signal. 2017 Sep;11(3):227-232. doi: 10.1007/s12079-017-0374-x. Epub 2017 Jan 31.

Prolactin secreting pituitary adenomas (prolactinomas) is the most common pituitary tumors in humans. Animal studies have identified aggressive prolactinoma development in fetal alcohol exposed rats. We have recently identified a combination treatment of a μ opioid receptor antagonist naltrexone...

Cite
Maglakelidze G, Wynne O, Sarkar DK. A combined opiate agonist and antagonist treatment reduces prolactin secreting pituitary tumor growth. J Cell Commun Signal. 2017;11(3):227-232doi: 10.1007/s12079-017-0374-x.
Maglakelidze, G., Wynne, O., & Sarkar, D. K. (2017). A combined opiate agonist and antagonist treatment reduces prolactin secreting pituitary tumor growth. Journal of cell communication and signaling, 11(3), 227-232. https://doi.org/10.1007/s12079-017-0374-x
Maglakelidze, George, et al. "A combined opiate agonist and antagonist treatment reduces prolactin secreting pituitary tumor growth." Journal of cell communication and signaling vol. 11,3 (2017): 227-232. doi: https://doi.org/10.1007/s12079-017-0374-x
Maglakelidze G, Wynne O, Sarkar DK. A combined opiate agonist and antagonist treatment reduces prolactin secreting pituitary tumor growth. J Cell Commun Signal. 2017 Sep;11(3):227-232. doi: 10.1007/s12079-017-0374-x. Epub 2017 Jan 31. PMID: 28144772; PMCID: PMC5559393.
Copy Download .nbib Format: NLM
Unfriendly Fire: How the Tobacco Industry is Destroying the Future of Our Children.

Acta medica Lituanica

Bush A, Ferkol T, Valiulis A, Mazur A, Chkhaidze I, Maglakelidze T, Sargsyan S, Boyajyan G, Cirstea O, Doan S, Katilov O, Pokhylko V, Dubey L, Poluziorovienė E, Prokopčiuk N, Taminskienė V, Valiulis A.
PMID: 34393624
Acta Med Litu. 2021;28(1):6-18. doi: 10.15388/Amed.2020.28.1.6. Epub 2021 Feb 08.

Tobacco has long been known to be one of the greatest causes of morbidity and mortality in the adults, but the effects on the foetus and young children, which are lifelong, have been less well appreciated. Developing from this...

Cite
Bush A, Ferkol T, Valiulis A, et al. Unfriendly Fire: How the Tobacco Industry is Destroying the Future of Our Children. Acta Med Litu. 2021;28(1):6-18doi: 10.15388/Amed.2020.28.1.6.
Bush, A., Ferkol, T., Valiulis, A., Mazur, A., Chkhaidze, I., Maglakelidze, T., Sargsyan, S., Boyajyan, G., Cirstea, O., Doan, S., Katilov, O., Pokhylko, V., Dubey, L., Poluziorovienė, E., Prokopčiuk, N., Taminskienė, V., & Valiulis, A. (2021). Unfriendly Fire: How the Tobacco Industry is Destroying the Future of Our Children. Acta medica Lituanica, 28(1), 6-18. https://doi.org/10.15388/Amed.2020.28.1.6
Bush, Andrew, et al. "Unfriendly Fire: How the Tobacco Industry is Destroying the Future of Our Children." Acta medica Lituanica vol. 28,1 (2021): 6-18. doi: https://doi.org/10.15388/Amed.2020.28.1.6
Bush A, Ferkol T, Valiulis A, Mazur A, Chkhaidze I, Maglakelidze T, Sargsyan S, Boyajyan G, Cirstea O, Doan S, Katilov O, Pokhylko V, Dubey L, Poluziorovienė E, Prokopčiuk N, Taminskienė V, Valiulis A. Unfriendly Fire: How the Tobacco Industry is Destroying the Future of Our Children. Acta Med Litu. 2021;28(1):6-18. doi: 10.15388/Amed.2020.28.1.6. Epub 2021 Feb 08. PMID: 34393624; PMCID: PMC8311841.
Copy Download .nbib Format: NLM
Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies.

Cancer management and research

Hussein M, Maglakelidze M, Richards DA, Sabatini M, Gersten TA, Lerro K, Sinielnikov I, Spira A, Pritchett Y, Antal JM, Malik R, Beck JT.
PMID: 34408488
Cancer Manag Res. 2021 Aug 09;13:6207-6218. doi: 10.2147/CMAR.S313045. eCollection 2021.

PURPOSE: Trilaciclib is an intravenous cyclin-dependent kinase 4/6 inhibitor indicated to decrease the incidence of chemotherapy-induced myelosuppression (CIM) by protecting hematopoietic stem and progenitor cells and immune system function from chemotherapy-induced damage (myeloprotection). Here, we investigated the myeloprotective effects...

Cite
Hussein M, Maglakelidze M, Richards DA, et al. Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies. Cancer Manag Res. 2021;13:6207-6218doi: 10.2147/CMAR.S313045.
Hussein, M., Maglakelidze, M., Richards, D. A., Sabatini, M., Gersten, T. A., Lerro, K., Sinielnikov, I., Spira, A., Pritchett, Y., Antal, J. M., Malik, R., & Beck, J. T. (2021). Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies. Cancer management and research, 136207-6218. https://doi.org/10.2147/CMAR.S313045
Hussein, Maen, et al. "Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies." Cancer management and research vol. 13 (2021): 6207-6218. doi: https://doi.org/10.2147/CMAR.S313045
Hussein M, Maglakelidze M, Richards DA, Sabatini M, Gersten TA, Lerro K, Sinielnikov I, Spira A, Pritchett Y, Antal JM, Malik R, Beck JT. Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies. Cancer Manag Res. 2021 Aug 09;13:6207-6218. doi: 10.2147/CMAR.S313045. eCollection 2021. PMID: 34408488; PMCID: PMC8363477.
Copy Download .nbib Format: NLM
Helsinki by nature: The Nature Step to Respiratory Health.

Clinical and translational allergy

Haahtela T, von Hertzen L, Anto JM, Bai C, Baigenzhin A, Bateman ED, Behera D, Bennoor K, Camargos P, Chavannes N, de Sousa JC, Cruz A, Do Céu Teixeira M, Erhola M, Furman E, Gemicioğlu B, Gonzalez Diaz S, Hellings PW, Jousilahti P, Khaltaev N, Kolek V, Kuna P, La Grutta S, Lan LTT, Maglakelidze T, Masjedi MR, Mihaltan F, Mohammad Y, Nunes E, Nyberg A, Quel J, Rosado-Pinto J, Sagara H, Samolinski B, Schraufnagel D, Sooronbaev T, Tag Eldin M, To T, Valiulis A, Varghese C, Vasankari T, Viegi G, Winders T, Yañez A, Yorgancioğlu A, Yusuf O, Bousquet J, Billo NE.
PMID: 31695865
Clin Transl Allergy. 2019 Oct 30;9:57. doi: 10.1186/s13601-019-0295-2. eCollection 2019.

RESULTS: The concept of the Nature Step has evolved from innovative research indicating, how changed lifestyle in urban surroundings reduces contact with biodiverse environments, impoverishes microbiota, affects immune regulation and increases risk of NCDs. The Nature Step calls for...

Cite
Haahtela T, von Hertzen L, Anto JM, et al. Helsinki by nature: The Nature Step to Respiratory Health. Clin Transl Allergy. 2019;9:57doi: 10.1186/s13601-019-0295-2.
Haahtela, T., von Hertzen, L., Anto, J. M., Bai, C., Baigenzhin, A., Bateman, E. D., Behera, D., Bennoor, K., Camargos, P., Chavannes, N., de Sousa, J. C., Cruz, A., Do Céu Teixeira, M., Erhola, M., Furman, E., Gemicioğlu, B., Gonzalez Diaz, S., Hellings, P. W., Jousilahti, P., Khaltaev, N., Kolek, V., Kuna, P., La Grutta, S., Lan, L. T. T., Maglakelidze, T., Masjedi, M. R., Mihaltan, F., Mohammad, Y., Nunes, E., Nyberg, A., Quel, J., Rosado-Pinto, J., Sagara, H., Samolinski, B., Schraufnagel, D., Sooronbaev, T., Tag Eldin, M., To, T., Valiulis, A., Varghese, C., Vasankari, T., Viegi, G., Winders, T., Yañez, A., Yorgancioğlu, A., Yusuf, O., Bousquet, J., & Billo, N. E. (2019). Helsinki by nature: The Nature Step to Respiratory Health. Clinical and translational allergy, 957. https://doi.org/10.1186/s13601-019-0295-2
Haahtela, Tari, et al. "Helsinki by nature: The Nature Step to Respiratory Health." Clinical and translational allergy vol. 9 (2019): 57. doi: https://doi.org/10.1186/s13601-019-0295-2
Haahtela T, von Hertzen L, Anto JM, Bai C, Baigenzhin A, Bateman ED, Behera D, Bennoor K, Camargos P, Chavannes N, de Sousa JC, Cruz A, Do Céu Teixeira M, Erhola M, Furman E, Gemicioğlu B, Gonzalez Diaz S, Hellings PW, Jousilahti P, Khaltaev N, Kolek V, Kuna P, La Grutta S, Lan LTT, Maglakelidze T, Masjedi MR, Mihaltan F, Mohammad Y, Nunes E, Nyberg A, Quel J, Rosado-Pinto J, Sagara H, Samolinski B, Schraufnagel D, Sooronbaev T, Tag Eldin M, To T, Valiulis A, Varghese C, Vasankari T, Viegi G, Winders T, Yañez A, Yorgancioğlu A, Yusuf O, Bousquet J, Billo NE. Helsinki by nature: The Nature Step to Respiratory Health. Clin Transl Allergy. 2019 Oct 30;9:57. doi: 10.1186/s13601-019-0295-2. eCollection 2019. PMID: 31695865; PMCID: PMC6822361.
Copy Download .nbib Format: NLM
Accuracy and cost-effectiveness of different screening strategies for identifying undiagnosed COPD among primary care patients (≥40 years) in China: a cross-sectional screening test accuracy study: findings from the Breathe Well group.

BMJ open

Pan Z, Dickens AP, Chi C, Kong X, Enocson A, G Cooper B, Adab P, Cheng KK, Sitch AJ, Jowett S, Adams R, Correia-de-Sousa J, Farley A, Gale NK, Jolly K, Maglakelidze M, Maglakelidze T, M Martins S, Stavrikj K, Stelmach R, Turner AM, Williams S, E Jordan R.
PMID: 34556515
BMJ Open. 2021 Sep 23;11(9):e051811. doi: 10.1136/bmjopen-2021-051811.

OBJECTIVES: To examine the accuracy and cost-effectiveness of various chronic obstructive pulmonary disease (COPD) screening tests and combinations within a Chinese primary care population.DESIGN: Screening test accuracy study.SETTING: Urban and rural community health centres in four municipalities of China:...

Cite
Pan Z, Dickens AP, Chi C, et al. Accuracy and cost-effectiveness of different screening strategies for identifying undiagnosed COPD among primary care patients (≥40 years) in China: a cross-sectional screening test accuracy study: findings from the Breathe Well group. BMJ Open. 2021;11(9):e051811doi: 10.1136/bmjopen-2021-051811.
Pan, Z., Dickens, A. P., Chi, C., Kong, X., Enocson, A., G Cooper, B., Adab, P., Cheng, K. K., Sitch, A. J., Jowett, S., Adams, R., Correia-de-Sousa, J., Farley, A., Gale, N. K., Jolly, K., Maglakelidze, M., Maglakelidze, T., M Martins, S., Stavrikj, K., Stelmach, R., Turner, A. M., Williams, S., & E Jordan, R. (2021). Accuracy and cost-effectiveness of different screening strategies for identifying undiagnosed COPD among primary care patients (≥40 years) in China: a cross-sectional screening test accuracy study: findings from the Breathe Well group. BMJ open, 11(9), e051811. https://doi.org/10.1136/bmjopen-2021-051811
Pan, Zihan, et al. "Accuracy and cost-effectiveness of different screening strategies for identifying undiagnosed COPD among primary care patients (≥40 years) in China: a cross-sectional screening test accuracy study: findings from the Breathe Well group." BMJ open vol. 11,9 (2021): e051811. doi: https://doi.org/10.1136/bmjopen-2021-051811
Pan Z, Dickens AP, Chi C, Kong X, Enocson A, G Cooper B, Adab P, Cheng KK, Sitch AJ, Jowett S, Adams R, Correia-de-Sousa J, Farley A, Gale NK, Jolly K, Maglakelidze M, Maglakelidze T, M Martins S, Stavrikj K, Stelmach R, Turner AM, Williams S, E Jordan R. Accuracy and cost-effectiveness of different screening strategies for identifying undiagnosed COPD among primary care patients (≥40 years) in China: a cross-sectional screening test accuracy study: findings from the Breathe Well group. BMJ Open. 2021 Sep 23;11(9):e051811. doi: 10.1136/bmjopen-2021-051811. PMID: 34556515; PMCID: PMC8461701.
Copy Download .nbib Format: NLM
A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?.

Pulmonary therapy

Maglakelidze N, Manto KM, Craig TJ.
PMID: 32405877
Pulm Ther. 2020 Dec;6(2):169-176. doi: 10.1007/s41030-020-00118-5. Epub 2020 May 13.

INTRODUCTION: COVID-19 presentation may include a profound increase in cytokines and associated pneumonia, rapidly progressing to acute respiratory distress syndrome (ARDS). This so-called cytokine storm often leads to refractory edema, respiratory arrest, and death. At present, anti-IL-6, antiviral therapy,...

Cite
Maglakelidze N, Manto KM, Craig TJ. A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?. Pulm Ther. 2020;6(2):169-176doi: 10.1007/s41030-020-00118-5.
Maglakelidze, N., Manto, K. M., & Craig, T. J. (2020). A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?. Pulmonary therapy, 6(2), 169-176. https://doi.org/10.1007/s41030-020-00118-5
Maglakelidze, Natella, et al. "A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?." Pulmonary therapy vol. 6,2 (2020): 169-176. doi: https://doi.org/10.1007/s41030-020-00118-5
Maglakelidze N, Manto KM, Craig TJ. A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?. Pulm Ther. 2020 Dec;6(2):169-176. doi: 10.1007/s41030-020-00118-5. Epub 2020 May 13. PMID: 32405877; PMCID: PMC7218701.
Copy Download .nbib Format: NLM
Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001.

Clinical cancer research : an official journal of the American Association for Cancer Research

Wiedermann U, Garner-Spitzer E, Chao Y, Maglakelidze M, Bulat I, Dechaphunkul A, Arpornwirat W, Charoentum C, Yen CJ, Yau TC, Tanasanvimon S, Maneechavakajorn J, Sookprasert A, Bai LY, Chou WC, Ungtrakul T, Drinic M, Tobias J, Zielinski CC, Chong L, Ede NJ, Marino MT, Good AJ.
PMID: 33879458
Clin Cancer Res. 2021 Jul 01;27(13):3649-3660. doi: 10.1158/1078-0432.CCR-20-3742. Epub 2021 Apr 20.

PURPOSE: HER2/neu is overexpressed in up to 30% of gastroesophageal adenocarcinomas (GEA) and linked to poor prognosis. Recombinant mAbs to treat HER2/neu-overexpressing cancers are effective with limitations, including resistance and toxicity. Therefore, we developed a therapeutic B-cell epitope vaccine...

Cite
Wiedermann U, Garner-Spitzer E, Chao Y, et al. Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001. Clin Cancer Res. 2021;27(13):3649-3660doi: 10.1158/1078-0432.CCR-20-3742.
Wiedermann, U., Garner-Spitzer, E., Chao, Y., Maglakelidze, M., Bulat, I., Dechaphunkul, A., Arpornwirat, W., Charoentum, C., Yen, C. J., Yau, T. C., Tanasanvimon, S., Maneechavakajorn, J., Sookprasert, A., Bai, L. Y., Chou, W. C., Ungtrakul, T., Drinic, M., Tobias, J., Zielinski, C. C., Chong, L., Ede, N. J., Marino, M. T., & Good, A. J. (2021). Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(13), 3649-3660. https://doi.org/10.1158/1078-0432.CCR-20-3742
Wiedermann, Ursula, et al. "Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,13 (2021): 3649-3660. doi: https://doi.org/10.1158/1078-0432.CCR-20-3742
Wiedermann U, Garner-Spitzer E, Chao Y, Maglakelidze M, Bulat I, Dechaphunkul A, Arpornwirat W, Charoentum C, Yen CJ, Yau TC, Tanasanvimon S, Maneechavakajorn J, Sookprasert A, Bai LY, Chou WC, Ungtrakul T, Drinic M, Tobias J, Zielinski CC, Chong L, Ede NJ, Marino MT, Good AJ. Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001. Clin Cancer Res. 2021 Jul 01;27(13):3649-3660. doi: 10.1158/1078-0432.CCR-20-3742. Epub 2021 Apr 20. PMID: 33879458.
Copy Download .nbib Format: NLM
A planetary health blind spot: the untapped potential of women to safeguard nature and human resilience in LMICs.

The Lancet. Planetary health

de Paula N, Jung L, Mar K, Bowen K, Maglakelidze M, Fünderich M, Otieno M, El Omrani O, Baunach S, Gepp S.
PMID: 33691087
Lancet Planet Health. 2021 Mar;5(3):e109-e110. doi: 10.1016/S2542-5196(21)00007-3. Epub 2021 Mar 07.

No abstract available.

Cite
de Paula N, Jung L, Mar K, et al. A planetary health blind spot: the untapped potential of women to safeguard nature and human resilience in LMICs. Lancet Planet Health. 2021;5(3):e109-e110doi: 10.1016/S2542-5196(21)00007-3.
de Paula, N., Jung, L., Mar, K., Bowen, K., Maglakelidze, M., Fünderich, M., Otieno, M., El Omrani, O., Baunach, S., & Gepp, S. (2021). A planetary health blind spot: the untapped potential of women to safeguard nature and human resilience in LMICs. The Lancet. Planetary health, 5(3), e109-e110. https://doi.org/10.1016/S2542-5196(21)00007-3
de Paula, Nicole, et al. "A planetary health blind spot: the untapped potential of women to safeguard nature and human resilience in LMICs." The Lancet. Planetary health vol. 5,3 (2021): e109-e110. doi: https://doi.org/10.1016/S2542-5196(21)00007-3
de Paula N, Jung L, Mar K, Bowen K, Maglakelidze M, Fünderich M, Otieno M, El Omrani O, Baunach S, Gepp S. A planetary health blind spot: the untapped potential of women to safeguard nature and human resilience in LMICs. Lancet Planet Health. 2021 Mar;5(3):e109-e110. doi: 10.1016/S2542-5196(21)00007-3. Epub 2021 Mar 07. PMID: 33691087.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 12 entries